Previous Close | 5.41 |
Open | 5.47 |
Bid | 5.64 x 2200 |
Ask | 5.93 x 800 |
Day's Range | 5.42 - 5.71 |
52 Week Range | 4.41 - 10.30 |
Volume | |
Avg. Volume | 153,066 |
Market Cap | 134.382M |
Beta (5Y Monthly) | 0.40 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.14 |
Earnings Date | Jun 29, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 30.67 |
Subscribe to Yahoo Finance Plus to view Fair Value for ATNM
Organogenesis (ORGO) delivered earnings and revenue surprises of 12.50% and 0.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Aurinia (AUPH) delivered earnings and revenue surprises of -13.64% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Here is how Alkermes (ALKS) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.